Brain Tumors

Infratentorial Craniotomy

Survival: Infratentorial Craniotomy

2017 – 2021

The 30- and 180-day survival rates for infratentorial craniotomy were 100% for 2021.

Inpatient Mortality: Infratentorial Craniotomy

2017 – 2021

ᵃThe 3M™ All Patient Refined Diagnosis Related Groups (APR-DRG) Classification System is used for adjusting data for severity of illness and risk of mortality.

There has been only 1 death in patients undergoing infratentorial craniotomy at Cleveland Clinic in the past 5 years, which is below the expected number based on national averages. N = number of infratentorial craniotomies performed for brain tumor per year. In 2021 there were 1.43% inpatient deaths vs an expected mortality of 10.34%.

Average Length of Stay: Infratentorial Craniotomy

2017 – 2021

LOS = length of stay

ᵃThe 3M™ All Patient Refined Diagnosis Related Groups (APR-DRG) Classification System is used for adjusting data for severity of illness and risk of mortality.

Average length of stay has remained lower than predicted during the past 5 years.

Survival: Infratentorial Craniotomy for Glioma

2017 – 2021

Both the 30- and 180-day survival rates for infratentorial craniotomy for glioma were 100% for 2021.

Survival: Infratentorial Craniotomy for Meningioma

2017 – 2021

Both the 30- and 180-day survival rates for infratentorial craniotomy for meningioma were 100% for 2021.

Survival: Infratentorial Craniotomy for Metastasis

2017 – 2021

Both the 30- and 180-day survival rates for infratentorial craniotomy for brain metastasis were 100% for 2021.

Survival: Infratentorial Craniotomy for Schwannoma

2017 – 2021

Both the 30- and 180-day survival rates for infratentorial craniotomy for Schwannoma were 100% for 2021.